The U.S. government announced it is investing more than $3 billion to accelerate the discovery, development, and manufacturing of antiviral medicines as part of the whole-of-government strategy to develop the next generation of COVID-19 treatments.
Patients with cancer, transplant, and other immunocompromising conditions are at uncertain risk of severe COVID-19 illness. This study aimed to clarify whether patients with immunocompromising conditions were more likely to develop severe […]
Hospitals’ need for blood on the rise as they deal with many patients who delayed care due to the COVID-19 pandemic
Vaccine’s efficacy is the lowest reported so far by a COVID-19 vaccine maker
It is not clear yet whether, or when, booster shots might be necessary